Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques have?
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques has 33 citations in the OpenAlex counts ScholarIQ stores.
When was Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques published?
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques has 2015 year in the ScholarIQ index.
What is the open-access status of Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques?
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques has bronze oa status in the ScholarIQ index.
What is the DOI of Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques?
The DOI for Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques is on the source record.
What is the PMID of Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques?
The PMID for Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques is on the source record.
What is the OpenAlex record for Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques?
The OpenAlex for Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques is on the source record.